The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer Group.

[1]  H. Sather,et al.  Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  L. Robison,et al.  Second neoplasms after acute lymphoblastic leukemia in childhood. , 1991, The New England journal of medicine.

[3]  Denis R. Miller,et al.  Lymphomatous presentation of childhood acute lymphoblastic leukemia. A subgroup at high risk of early treatment failure , 1991, Cancer.

[4]  R. Gelber,et al.  Improved methodology for analyzing local and distant recurrence. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  G. Dalrymple,et al.  CNS tumor induction by radiotherapy: a report of four new cases and estimate of dose required. , 1990, International journal of radiation oncology, biology, physics.

[6]  A. Meadows,et al.  Educational late effects in long-term survivors of childhood acute lymphocytic leukemia. , 1988, Pediatrics.

[7]  L. Robison,et al.  Long-term evaluation of a CNS prophylaxis trial--treatment comparisons and outcome after CNS relapse in childhood ALL: a report from the Childrens Cancer Study Group. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  A. Bleyer,et al.  Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  John D. Kalbfleisch,et al.  The Statistical Analysis of Failure Data , 1986, IEEE Transactions on Reliability.

[10]  Bleyer Wa,et al.  Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. , 1985 .

[11]  A. Bleyer,et al.  Central nervous system (CNS) prophylaxis in children with low risk acute lymphoblastic leukemia (ALL). , 1984, International journal of radiation oncology, biology, physics.

[12]  J. Mann,et al.  Adjuvant low dose radiation in childhood T cell leukaemia/lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG). , 1984, British Journal of Cancer.

[13]  W. Bowman,et al.  Serial cranial computed-tomography scans in children with leukemia given two different forms of central nervous system therapy. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  E. Svarch,et al.  Comparison of central nervous system prophylaxis with cranial radiation and intrathecal methotrexate versus intrathecal methotrexate alone in acute lymphoblastic leukemia. , 1983, Blood.

[15]  H. Sather,et al.  Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Denis R. Miller,et al.  Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG‐141: A report from childrens cancer study group , 1983, Cancer.

[17]  James R. Anderson,et al.  Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). , 1983, The New England journal of medicine.

[18]  T. Necheles,et al.  Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children. , 1983, The New England journal of medicine.

[19]  J. Belli,et al.  Efficacy and morbidity of central nervous system prophylaxis in childhood acute lymphoblastic leukemia: eight years' experience with cranial irradiation and intrathecal methotrexate , 1983 .

[20]  K. Starling,et al.  Modified LSA2-L2 treatment in 53 children with E-rosette-positive T-cell leukemia: results and prognostic factors (a Pediatric Oncology Group Study). , 1982, Blood.

[21]  P. Dyment,et al.  Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study , 1982 .

[22]  J. Pullen,et al.  CNS prophylaxis in acute lymphoblastic leukemia. Comparison of two methods a southwest oncology group study , 1982, Cancer.

[23]  L. Robison,et al.  Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia: A Report from Children's Cancer Study Group. , 1982, Cancer research.

[24]  H. Gadner,et al.  Ergebnisse der Studie BFM 76/79 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen* , 1981 .

[25]  C. Eiser.  Intellectual abilities among survivors of childhood leukaemia as a function of CNS irradiation. , 1978, Archives of disease in childhood.

[26]  J. Burchenal,et al.  Non‐Hodgkin's lymphoma in children. A comparative study of two modalities of therapy , 1976, Cancer.

[27]  R. Aur,et al.  Prevention of central nervous system leukemia by irradiation , 1973, Cancer.

[28]  J. Peto,et al.  Asymptotically Efficient Rank Invariant Test Procedures , 1972 .

[29]  R. Aur,et al.  Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia. , 1971, Blood.

[30]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[31]  P. Wardman.  Molecular mechanisms of oxygen and "electron-affinic" radiosensitizers. , 1989, International journal of radiation oncology, biology, physics.

[32]  M. Williams,et al.  The role of cranial irradiation in low risk ALL. , 1989, International journal of radiation oncology, biology, physics.

[33]  P. Littman.  Response to Elyan and Williams , 1989 .

[34]  C. Pui,et al.  Efficacy of high-dose methotrexate in childhood acute lymphocytic leukemia: analysis by contemporary risk classifications. , 1988, Blood.

[35]  H. Sather,et al.  Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Report of Children's Cancer Study Group Study CCG-193P. , 1988, The American journal of pediatric hematology/oncology.

[36]  E. Halperin.  Pediatric radiation oncology. , 1986, Investigative radiology.

[37]  M. Gillin,et al.  Cranial irradiation in acute leukemia: dose estimate in the lens. , 1979, International journal of radiation oncology, biology, physics.